Please assess the completion status of the following clinical trial:

Trial Title: Supplementation With Cholecalciferol in Dialysis Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 25 (OH) \< 20 ng/ml~* Peritoneal dialysis or hemodialysis \> 3 months~Exclusion Criteria:~* Use of vitamin D or its analogues, corticosteroids and immunosuppressive~* Peritonitis in the previous month at baseline~* Liver, neoplastic, infectious or autoimmune diseases and positive HIV~* Hypercalcemia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): 100 drops/week for 12 weeks
- Cholecalciferol (Type: ACTIVE_COMPARATOR): Drug: Cholecalciferol - 100,000 IU/week

Based on this trial design, predict the completion outcome and termination type (if applicable).